soquelitinib
soquelitinib: sourced relationships with 1 company · 4 clinical trials tracked.
soquelitinib evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
How could soquelitinib → CRVS affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) Hidradenitis Suppurativa (HS); Atopic Dermatitis; Peripheral… | Phase 3 |
| Corvus Pharmaceuticals, Inc. (CRVS) Hidradenitis Suppurativa (HS); Atopic Dermatitis; Peripheral… | Phase 3 |
Clinical Trial Registry Records (4)
A Phase 1b, Open-label Study Evaluating the Safety and Efficacy of Oral Soquelitinib in Adults With Moderate-to-Severe Hidradenitis Suppurativa
Primary endpoint: Incidence of adverse events, changes in laboratory values, vital signs, and ECGs
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)
Primary endpoint: Percent change from baseline in Eczema Area and Severity Index (EASI) score at Week 12
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician's Choice Standard of Care Treatment (Selected Single Agent) in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Primary endpoint: Progression-free survival
A Phase 1, Randomized, Blinded, Placebo-controlled, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of ITK Inhibitor Soquelitinib in Participants With Moderate to Severe Atopic Dermatitis
Primary endpoint: Incidence of adverse events, changes in laboratory values, vital signs, and electrocardiograms
Frequently asked questions
Which companies have sourced relationships with soquelitinib?
soquelitinib has dated SEC/FDA relationship records for Corvus Pharmaceuticals, Inc..
How many clinical trials involve soquelitinib?
BioSniper tracks 4 clinical trials involving soquelitinib.